NextWave Pharmaceuticals and Tris Pharma Enter into CNS-focused Development and Commercialization Agreement (August, 2010)

Tris Pharma Announces Approval of First-Time Generic of Methylphenidate Hydrochloride Oral Solution With Six Months Exclusivity (July, 2010)

Perrigo Acquires Exclusive Sales and Distribution Rights to Generic Version of Delsym(R) from Tris Pharma (May, 2010)

Tris Pharma Announces Key Executive Hiring of Vice President of Corporate Development (April, 2010)

Tris Pharma Announces Two NDA Approvals from FDA including a Pioneering, First-Ever 24 hour Liquid Sustained Release Product (Dec, 2009)

FDA Accepts Tris Pharma's ANDA with Paragraph IV certification for a generic equivalent to Delsym (July, 2009)

Tris Pharma Announces Acceptance of Its First Two NDAs (May, 2009)

Tris Pharma's New Tool Fights Against Prescription Drug Abuse (November, 2008)

Tris Pharma Completes Its Facilities' Expansion, Receives FDA Clearance (September, 2008)

Edison Innovation Fund Helps Tris Pharma Expand (November, 2007)

Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development (November, 2007)

Alpharma licenses novel technology from Tris Pharma (March 29, 2007)

Tris Pharma Unveils Expansion of State-Of-The-Art-Research Facility (October 16, 2006)

Tris Pharma to exhibit at the 2006 AAPS Annual Meeting and Exposition from October 29 - November 2. This year's show will be at the Henry B. Gonzalez Convention Center in San Antonio, TX.

Interpharm Announces Agreements with Tris Pharma to Expand New Product Development; Collaboration on 32 Products, Including 25 Liquid Products (March 02, 2005)

Tris Expands, Adds Jobs with Second EDA Financing (January 26, 2004)